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THE TAP TEST- AN ACCURATE 
FIRST-LINE TEST FOR FETAL LUNG 
MATURITY TESTING 
W K H Kuchenbecker, L R Pistorius, R C Pattinson 
Objective. To determine the accuracy of near-patient and 
laboratory-based fetal lung maturity tests in predicting the 
need for neonatal ventilation. 
Design. A prospective descriptive study. 
Subjects. One hundred high-risk obstetric patients where 
confirmation of fetal lung maturity would initiate delivery. 
Methods. Fetal weight estimation, placental maturity 
grading, and amniocentesis were performed. The 
investigators examirted the amniotic fluid visually, and 
performed the tap test and shake test. Laboratory 
technicians estimated the lecithin-sphingomyelin (L/S) 
ratio, determined the presence of a phosphatidyl glycerol 
(PC) band on gel electrophoresis, and the optical density at 
650 nm. Neonates delivered within 1 week of 
amniocentesis were included in the analysis. The primary 
end-point was the ability of the lung maturity tests to 
predict the need for neonatal ventilation. 
Results. Twelve of 100 neonates required ventilation. The 
tap test and optical density (OD) shift at 650 nm predicted 
the need for neonatal ventilation with the greatest accuracy. 
Conclusion. The tap test is a rapid, easy and accurate 
predictor of the need for neonatal ventilation. The OD shift 
at 650 nm is the laboratory-based test with the greatest 
accuracy in our setting. 
S Afr Med J 2002; 92: 720-722. 
Preterm delivery of the medically compromised obstetric 
patient poses the risk of delivering an immature infant. This 
risk is difficult to quantify when uncertainty exists about the 
gestational age. One of the main contributors to the neonatal 
morbidity of the immature infant is hyaline membrane 
disease.1 Fetal lung maturity testing, performed on amniotic 
fluid, can be used to avoid hyaline membrane disease. On the 
other hand, delivery can be initiated when fetal lung maturity 
is deemed likely. 
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The estimation of the lecithin/sphingomyelin (L/S) ratio in 
amniotic fluid was described by Gluck and Kulovich' to 
confirm fetal lung maturity. It is still the mainstay of fetal lung 
maturity testing/together with the presence of a phosphatidyl 
glycerol (PC) band on gel electrophoresis.' These tests are time 
consuming and costly, require extensive training to perform, 
and are not always readily available after hours. The main 
disadvantage, however, remains the high rate of false 
immature results.' 
A near-patient test such as the shake test has the advantage 
that it can be done at the patient's bedside. Decisions about 
delivery or expectant management can therefore be made 
without undue delay. The shake test is also widely promoted 
as a bedside test of fetal lung maturity.'· 7 Unfortunately, the 
shake test has a high rate of false immature results. A false 
immature result is safe from the fetal or neonatal point of view, 
but puts the mother at unnecessary risk. Different studies'-11 
have shown that the tap test is as good a predictor of maturity, 
but a better predictor of immaturity, than the shake test.'-11 The 
present study was therefore undertaken to evaluate the ability 
of different near-patient and laboratory tests to predict fetal 
lung maturity. 
PATIENTS AND METHODS 
A prospective study was done on 100 high-risk obstetric 
patients. Patients qualified for inclusion in the study if 
uncertainty existed about the gestational age, if the estimated 
fetal weight was between 500 and 2 500 g, and if the patient's 
medical condition warranted elective delivery if fetal lung 
maturity was predicted. Patients were excluded from the 
study in cases of diabetes mellitus or multiple pregnancy, 
where the patient was younger than 18 years, where informed 
consent could not be obtained, and where the delay between 
amniocentesis and delivery was longer than 1 week The L/S 
ratio was taken as the gold standard and the results of the 
other tests were not made available to the clinicians. Results of 
the L/5 ratio normally take 12- 18 hours to be made available 
to the managing clinicians. _ 
The patient's age, indication for elective delivery, estimation 
of gestational age and estimated fetal weight were noted. 
Betamethasone was given to promote fetal lung maturity at a 
dose of 12 mg, repeated after 12 - 24 hours. The amniocentesis 
was dorie during the time when the corticosteroids were given. 
Detailed obstetric ultrasound was undertaken, including 
placental maturity grading1' and fetal weight estimation. 13• 14 
A Toshiba Sonolayer SSA-250 (Teemed, Halfway House, 
South Africa) with a 3.5 MHz curvilinear probe was used. 
When grade III maturity changes were seen in all areas of the 
placenta, it was recorded as mature. When no grade III 
changes were seen, the placental maturity grading was 
recorded as immature, and when it was seen in part of the 
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placenta, it was recorded as inconclusive." After obtaining 
informed consent, amniocentesis was done by the managing 
registrar or consultant under sterile conditions using a 20G 
spinal needle under sonographic guidance. Contamination of 
the amniotic fluid, as well as any complications of the 
procedure were noted. Amniotic fluid samples contaminated 
with blood, meconium or mucus were centrifuged at 400 g for 
5 minutes before further testing. Three millilitres of amniotic 
fluid were reserved for near-patient testing. The remainder of 
a volume of 10 ml was dispatched to the laboratory for 
determination of L/S ratio, PG band and difference in optical 
density at 650 nm. 
Near-patient testing of the amniotic fluid included visual 
assessment, the shake test and the tap test. If it was impossible 
to read newsprint through a 12 mm diameter glass tube filled 
with amniotic fluid, the visual assessment was deemed mature. 
Clear fluid was recorded as immature, and doubtful cases as 
inconclusive.15 
To perform the shake test, 1 ml of amniotic fluid was placed 
in an 85 x 12 mm test tube together with 1 ml95% ethanol (1:1 
solution). In another test tube, 0.5 ml of amniotic fluid and 
0.5 ml 0.9% saline were placed together with 1 ml 95% ethanol 
(1:2 solution). Both tubes were shaken for 15 seconds, and 
placed in an upright rack for 15 minutes. Persistence of a 360° 
ring of bubbles at the air-liquid interface in the 1:2 solution was 
interpreted to predict maturity. Clumping of bubbles that 
would create a 360° ring if spread out was also considered 
mature. If no bubbles persisted in either solution, the test was 
considered immature. If the 1:1 solution was considered 
mature and the 1:2 solution immature, the test was recorded as 
being inconclusive. 
To perform the tap test, one drop of 6N hydrochloric acid 
was added to 1 ml of amniotic fluid in an 85 x 12 mm glass test 
tube. Diethyl ether (1.5 ml) was added to form a layer on top of 
the amniotic fluid. The test tube was tapped briskly three or 
four times to form 200 - 300 bubbles in the ether layer. If more 
than five bubbles remained in the ether layer after 10 minutes, 
the test was considered immature. If five or less bubbles 
remained in the ether layer after 10 minutes, the test was 
considered mature.' 
In the laboratory the phospholipids were extracted using a 
chloroform-methanol mixture and then separated by two-
dimensional thin-layer chromatography. The results were 
compared with control solutions of L/S standard 2:1 and PG 
standard.16 The optic density at 650 nm was assessed 
spectrophotometrically.17 
After delivery, the time interval from amniocentesis to 
delivery was noted. The need for neonatal ventilation, as well 
as the indication for ventilation, were also noted. 
Epi-info version 6.1 (WHO 1993) was used to calculate the 
sensitivity, specificity, positive and negative predictive value 
and 95% confidence intervals of the different tests. 
The ethics committee of the University of Pretoria approved 
the study. 
RESULTS 
One hundred and eleven patients qualified for inclusion in the 
trial. Two patients did not provide informed consent. Nine 
patients delivered more than 1 week after amniocentesis, and 
were excluded from analysis. All 9 had an L/S ratio less than 2 
and hence were not delivered. The indications for the 
amniocentesis were proteinuric hypertension (N =55), fetal 
growth impairment (N = 15), preterm labour (N = 11), preterm 
ruptured membranes (N = 4), antepartum haemorrhage 
(N = 7), poor obstetric history (N = 6) and 11 other indications. 
Complications of amniocentesis included 5 patients with an 
unsuccessful first attempt at amniocentesis, and 5 bloody taps. 
Fourteen samples were contaminated with meconium. In 3 
patients ruptured membranes were confirmed within 24 hours 
of amniocentesis. All of these patients delivered within the 
week. Ten neonates required ventilation for hyaline membrane 
disease, 1 for congenital pneumonia, and 1 for asphyxia 
neonatorum. Two neonates were not ventilated because of a 
shortage of ventilators in the neonatal intensive care unit, and a 
poor prognosis owing to extreme multi-organ immaturity. The 
predictive value of the different tests with regard to the need 
for ventilation is depicted in Table I. 
DISCUSSION 
Accurate prediction of fetal lung maturity is crucial in the 
management of high-risk obstetric patients, especially those 
with unsure gestational age. 
This investigation shows that the tap test is an easy and 
reliable bedside test for fetal lung maturity, with better 
predictive values for ventilation than the shake test and 
conventional laboratory tests. These results are supported by 
other data from the literature (Table II). 
The lower predictive value for immaturity in this study can 
be explained on three grounds. In this study, there was a longer 
amniocentesis-delivery interval, corticosteroids for fetal lung 
maturation were not withheld, and the final end-point used, 
namely neonatal ventilation, was more strict than the diagnostic 
category of hyaline membrane disease, the spectrum of which 
includes mild disease. 
In line with the proposal of a cascade system of fetal lung 
maturity testing by Garite and Freeman/' the tap test can fill 
surely be instituted as first-line testing. However, strict 
adherence to the test description is necessary. 
A test predicting maturity can initiate delivery even in a 
secondary hospital, while a test predicting immaturity should 
initiate immediate referral of the patient to a tertiary centre, 
where expectant management could be considered. If delivery 
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Table I. Accuracy of different tests in predicting the need for neonatal ventilation (%, (% range), N) 
Test Sensitivity Specificity Predictive value for ventilation Predictive value for absence of ventilation 
Placental 80 11 8 86 
maturity (30-99) (5-23) (3-19) (42-99) 
grading 4/5 6/54 4/52 6/7 
Visual 83 45 17 95 
assessment (51-97) (34-56) (9-30) (82-99) 
10/12 39/87 10/58 39/41 
Shake test 100 10 13 100 
(70-100) (5-19) (7-23) (63-100) 
12/12 9/87 12/90 9/9 
Tap test 92 84 44 99 
(60-99) (74-91) (25-65) (92-100) 
11/12 73/87 11/25 73/74 
Optical density 100 79 46 100 
(66-100) (66-88) (25-67) (90-100) 
10/10 45/57 10/22 45/45 
L/S ratio 100 55 23 100 
(68-100) (44-66) (13-38) (90-100) 
11/11 45/82 11/48 45/45 
Phosphatidyl glycerol 100 59 25 100 
(68-100) (48-70) (14-40) (91-100) 
11/11 48/81 11/44 48/48 
L/S ~ lecithin· sphingomyelin. 
Table II. Comparison of studies on the tap test with respect to their predictive values for the endpoints used 
Predictive value Predictive 
of immature value of mature 
Tap test test(%) test(%) End-point 
Socol• 









is indicated in the face of predicted neonatal pulmonary 
immaturity, the immediate availability of NICU facilities would 
offer the best chance of survival. This proposal could prevent 
unnecessary referrals, and on the other hand initiate early 
referral of patients where tertiary care is appropriate. In bigger 
centres with availability of spectrophotometers, an OD of 650 
nm can safely be initiated as the second-line test to confirm 
immaturity. This is less costly and time consuming than the 
LIS and PG estimations. Only contaminated specimens and 
immature prediction using OD 650 nm would necessitate 
testing of the full phospholipid profile. 
While fetal lung maturity testing in the First-World setting is 






Hyaline membrane disease 
Correlation with L/S ratio 
Hyaline membrane disease 
Hyaline membrane disease 
Neonatal ventilation 
not often indicated, accurate and easy fetal lung maturity tests 
in the developing world, where unsure gestational age is a 
common problem, is a valuable tool in the clinical management 
of high-risk obstetric patients. 
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IMPACT OF URBANISATION ON 
SERUM LIPID PROFILES -THE 
THUSA SURVEY 
W Oosthuizen, H H Vorster, A Kruger, C S Venter, 
H S Kruger, J H de Ridder 
Objective. To examine the impact of urbanisation on lipid 
profiles of black South Africans, stratified for HIV status. 
Design. Cross-sectional population-based survey. 
Setting. North West province of South Africa. 
Subjects. A representative sample of 1 854 apparently 
healthy volunteers aged ;::: 15 years, was recruited from 37 
randomly selected sites throughout the province. Subjects 
were stratified into five urbanisation strata (S): Sl rural 
villages, 52 farms, 53 informal housing or 'squatter camps', 
S4 urban townships, and 55 surburban housing. 
Outcome measures. Demographic, physical activity and 
dietary intake information was collected using validated 
and culture-sensitive questionnaires. A11thropometric 
measurements and lipid analyses were determined using 
standardised methodology. 
Results. The results revealed significantly lower mean(95% 
confidence interval) total serum cholesterol (TC) levels in 
HIV-negative men in Sl -54 compared with 55 (51 3.91 
(3.77- 4.05) v. 55 4.79 (4.54- 5.04) mmol/1). In HIV-negative 
women, TC levels were significantly lower in Sl - 53 than in 
54 and 55 (51 4.05 (3.94- 4.17) v. 55 4.79 (4.59- 5.00) 
mmol/1). The same trends were seen for serum low-density 
lipoprotein cholesterol (LDLC) and triglycerides and in 
HIV-positive subjects. Binary logistical analysis indicated 
that the main factor responsible for the increased TC levels 
seemed to be increased body mass index (BMI) due to 
decreased physical activity. 
Conclusions. Serum lipid levels increased with urbanisation 
although they remained within levels recommended for 
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